Ignite Creation Date:
2025-12-24 @ 12:43 PM
Ignite Modification Date:
2026-01-01 @ 8:16 AM
Study NCT ID:
NCT03009461
Status:
COMPLETED
Last Update Posted:
2024-12-04
First Post:
2017-01-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis
Sponsor:
Peking University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2020-06-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12-28
Completion Date Type:
ACTUAL
First Submit Date:
2017-01-02
First Submit QC Date:
None
Study First Post Date:
2017-01-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-01
Last Update Post Date:
2024-12-04
Last Update Post Date Type:
ACTUAL